Abstract
Background and aims Hyperglycemia induced by surgical stress often causes the dysregulation of liver metabolism and immune function resulting in impaired post-operative recovery. The aim of this study was to evaluate the usefulness of a closed-loop system providing continuous monitoring and strict control of post-operative blood glucose in patients after hepatic resection. Patients and methods A total of 19 patients who underwent hepatic resection for primary liver tumor between August and December 2006 were enrolled in the study. Following surgery, blood glucose was continuously monitored by the STG-22 closed-loop system. Glucose levels were controlled using either a manual injection of insulin according to the commonly used sliding scale (manual insulin group, n = 9) or a programmed infusion of insulin determined by the control algorithm of the STG-22 (programmed insulin group, n = 10). The total amount of insulin used in the first 16 h following hepatic resection in the two groups was measured. Results In the manual insulin group, post-operative blood glucose rose initially and reached a plateau of approximately 250 mg/dl between 4 h and 7 h post-hepatectomy and then returned towards normal levels by 16 h. In the programmed insulin group, blood glucose was steadily lowered, reaching the target zone (90–110 mg/dl) by 12 h post-surgery. The total amount of insulin administered per patient during the first 16 h post-surgery was significantly higher in the programmed insulin group (183 ± 188 IU) than in the manual insulin group (8 ± 7 IU; P < 0.001). No hypoglycemia was observed in either group. Conclusions Post-operative hyperglycemia was observed for up to 16 h in hepatectomized patients. In this post-operative hyperglycemic state, the STG-22 closed-loop system safely and quickly achieved glycemic control, indicating its clinical value in the post-operative management of hepatectomized patients.
Similar content being viewed by others
References
Cely CM, Arora P, Quartin AA, Kett DH, Schein RM (2004) Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 126:879–887
McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124
Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778
Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC et al (2003) Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 98:2293–2298
Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y (2002) Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 6:88–94
Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461
Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047
Toft P, Jorgensen HS, Toennesen E, Christiansen C (2006) Intensive insulin therapy to non-cardiac ICU patients: a prospective study. Eur J Anaesthesiol 23:705–709
Dronge A, Perkal MF, Kancir S, Concato J, Aslm M, Rosenthal R (2006) Long-term glycemic control and postoperative infectious complications. Arch Surg 141:375–380
Ishida T, Lewis RM, Hartley CJ, Entman ML, Field JB (1983) Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology 112:1098–2109
Pringle JH (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48:541
Hanazaki K, Nose Y, Brunicardi FC (2001) Artificial endocrine pancreas. J Am Coll Surg 193:310–322
Harris JA, Benedict FG (1918) A biometric study of human basal metabolism. Proc Natl Acad Sci USA 4:370–373
Alfonso A, Koops MK, Mong DP, Vigersky RA (2006) Glycemic control with regular versus lispro insulin sliding scales in hospitalized type 2 diabetics. J Diabetes Complications 20:153–157
Dickerson LM, Ye X, Sack JL, Hueston WJ (2003) Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized control trial. Ann Fam Med 1:29–35
Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356–361
Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang XP, Nose Y, Brunicardi FC (2005) Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs 29:83–87
Raucoules-Aime M, Roussel LJ, Rossi D, Gastaud P, Dolisi C, Grimaud D (1995) Effect of severity of surgery on metabolic control and insulin requirements in insulin-dependent diabetic patients. Br J Anaesth 74:231–233
Carli F (2006) Postoperative metabolic stress: interventional strategies. Minerva Anesthesiol 72:413–418
Ljungqvist O, Nygren J, Thorell A (2000) Insulin resistance and elective surgery. Surgery 128:757–760
Thorell A, Nygren J, Ljungqvist O (1999) Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 2:69–78
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982
Guvener M, Pasaoglu I, Demircin M, Oc M (2002) Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 49:531–537
Nolte W, Hartmann H, Ramadori G (1995) Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes 103:63–74
Chase JG, Hann CE, Jackson M, Lin J, Lotz T, Wong XW et al (2006) Integral-based filtering of continuous glucose sensor measurements for glycaemic control in critical care. Comput Methods Programs Biomed 82:238–247
Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH et al (2004) Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 77:703–710
Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S et al (2004) Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126:840–848
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okabayashi, T., Hnazaki, K., Nishimori, I. et al. Continuous Post-operative Blood Glucose Monitoring and Control Using a Closed-loop System in Patients Undergoing Hepatic Resection. Dig Dis Sci 53, 1405–1410 (2008). https://doi.org/10.1007/s10620-007-0010-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-0010-3